Procter & Gamble Hygiene and Health Care Ltd Q4 FY26 results (latest), Jan–Mar 2026 →Revenue ₹941 Cr −5.1% YoYSee revenue, profit and what management said. You are viewing Q3 FY19.
P&

Procter & Gamble Hygiene and Health Care Ltd

Q3 FY19Personal Products

Procter & Gamble Hygiene and Health Care Q3 FY19 earnings call: Revenue & Margins

Q3 FY19 investor presentation: what the company reported on revenue, margins and capex.

Procter & Gamble Hygiene and Health Care Ltd Q3 FY19 key numbers

Revenue
The presentation reports sales of approximately INR 2,500 Crore.

As stated in Procter & Gamble Hygiene and Health Care Ltd's Q3 FY19 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.

Based on Procter & Gamble Hygiene and Health Care Ltd's Q3 FY19 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹7,093
Market cap₹24.3K Cr
P/E30.7

The short version

The presentation reports sales of approximately INR 2,500 Crore (Page 16).

From Procter & Gamble Hygiene and Health Care Ltd's Q3 FY19 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • The presentation reports sales of approximately INR 2,500 Crore (Page 16).
  • Sales have grown 2.5 times over the past 7 years (from INR 1,003 Cr in 2011 to INR 2,455 Cr in 2018) (Page 16).
  • Profits (PAT) have also grown 2.5 times over the past 7 years (from INR 151 Cr in 2011 to INR 375 Cr in 2018) with PAT margins at 15% (Page 16).

2 more points from Procter & Gamble Hygiene and Health Care Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Procter & Gamble Hygiene and Health Care Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

It focuses primarily on overall business performance, innovation, local manufacturing (>99% products locally produced), profitability, market leadership, and shareholder value creation without specifying investment amounts or new project plans.

Top-ranked in Personal Products

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
2Recode Studios
Rev 1Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Procter & Gamble Hygiene and Health Care Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Procter & Gamble Hygiene and Health Care Ltd said on order book & pipeline — free account, 30 seconds.

Procter & Gamble Hygiene and Health Care Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.1K Cr, net profit ₹196 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Procter & Gamble Hygiene and Health Care Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Procter & Gamble Hygiene and Health Care Ltd Q3 FY19 results?

The presentation reports sales of approximately INR 2,500 Crore (Page 16).

What is Procter & Gamble Hygiene and Health Care Ltd share price analysis?

Procter & Gamble Hygiene and Health Care Ltd currently shows a neutral. The stock trades at a P/E of 30.7 with a market cap of ₹24,300 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Procter & Gamble Hygiene and Health Care Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.